A Comparison of Pharmacokinetic and Pharmacodynamic Properties Between Faster-Acting Insulin Aspart and Insulin Aspart in Elderly Subjects with Type 1 Diabetes Mellitus

Faster Onset and Greater Early Exposure and Glucose-Lowering Effect with Faster-Acting Insulin Aspart vs. Insulin Aspart: A Pooled Analysis in Subjects with Type 1 Diabetes

(2016) Tim Heise et al.   Canadian Journal of Diabetes

Pharmacokinetic and Pharmacodynamic Properties of Faster-Acting Insulin Aspart versus Insulin Aspart Across a Clinically Relevant Dose Range in Subjects with Type 1 Diabetes Mellitus

(2016) Tim Heise et al.   CLINICAL PHARMACOKINETICS

Faster-acting insulin aspart: earlier onset of appearance and greater early pharmacokinetic and pharmacodynamic effects than insulin aspart

(2015) T. Heise et al.   DIABETES OBESITY & METABOLISM

The Distinct Prandial and Basal Pharmacodynamics of IDegAsp Observed in Younger Adults Are Preserved in Elderly Subjects with Type 1 Diabetes

(2015) Martina Brunner et al.   DRUGS & AGING

Ultra-Long Pharmacokinetic Properties of Insulin Degludec are Comparable in Elderly Subjects and Younger Adults with Type 1 Diabetes Mellitus

(2013) S. Korsatko et al.   DRUGS & AGING

Diabetes and Altered Glucose Metabolism with Aging

(2013) Rita Rastogi Kalyani et al.   ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA

Diabetes in Older Adults

(2012) M. S. Kirkman et al.   DIABETES CARE

Insulin Use in Elderly Adults: Risk of Hypoglycemia and Strategies for Care

(2012) Robert J. Ligthelm et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

Insulin Therapy in the Elderly Patient With Diabetes

(2011) Lal K. Tanwani   American Journal Geriatric Pharmacotherapy

Diversity in diabetes: the role of insulin aspart

(2011) Simon Heller et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

The rapid-acting properties of insulin aspart are preserved in elderly people with type 2 diabetes*

(2008) R. Krones et al.   DIABETES OBESITY & METABOLISM